glp-1 efectos secundarios Fármacos para perder peso: ¿milagro o riesgo oculto? Lo que terapeutas y pacientes deben saber sobre los agonistas – HEALTHY INSTITUTE La revolución de los fármacos

Regular monitoring is important for people taking GLP-1 medication

Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level

There are other forms of bias in these datasets including channeling (e.g., the prescribing pattern depends on a patient characteristic (particularly diabetes or obesity) that is a PDAC risk factor), detection (e.g., overreporting due to additional testing to rule out a suspected adverse event (e.g., imaging triggered by pancreas enzyme elevations)), and Weber effect (initial increase in event reporting shortly after drug launch) 49

The most well-known weight loss drug in recent years has been Ozempic, but its not actually a weight loss drug